INMUNE BIO INC. Interest Income, Other
INMUNE BIO INC. (INMB) reported Interest Income, Other of $21.85 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2020-05-14
- INMUNE BIO INC. interest income, other for the quarter ending 2020-03-31 was $21.85K, a 117.63% increase year-over-year.
- INMUNE BIO INC. interest income, other for the quarter ending 2019-12-31 was $14.09K.
- INMUNE BIO INC. interest income, other for the quarter ending 2019-09-30 was $17.22K.
- INMUNE BIO INC. interest income, other for the quarter ending 2019-06-30 was $36.34K.
- INMUNE BIO INC. interest income, other for fiscal 2019 was $77.69K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2020-03-31 | $21.85K 10-Q · filed 2020-05-14 | $35.94K derived: sum of 2 quarters · filed 2020-05-14 | $53.16K derived: sum of 3 quarters · filed 2020-05-14 | $89.50K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-12-31 | $14.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $31.31K derived: sum of 2 quarters · filed 2020-03-11 | $67.65K derived: sum of 3 quarters · filed 2020-03-11 | $77.69K 10-K · filed 2020-03-11 |
| 2019-09-30 | $17.22K 10-Q · filed 2019-11-08 | $53.56K derived: sum of 2 quarters · filed 2019-11-08 | $63.60K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $36.34K 10-Q · filed 2019-08-09 | $46.38K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $10.04K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |